We are live on ! Find out more
PIM

Platinum Investment Management Portfolio holdings

AUM $397M
1-Year Est. Return 63.96%
This Fund
S&P 500
This Quarter Est. Return
+9.65%
1 Year Est. Return
+63.96%
3 Year Est. Return
+135%
5 Year Est. Return
+149.46%
10 Year Est. Return
+636.06%
AUM
$2.48B
AUM Growth
+$17.8M
Cap. Flow
-$127M
Cap. Flow %
-5.1%
Top 10 Hldgs %
64.83%
Holding
157
New
15
Increased
31
Reduced
63
Closed
18

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$126M
2
ZTO icon
ZTO Express
ZTO
+$60.1M
3
TRU icon
TransUnion
TRU
+$15.2M
4
MBLY icon
Mobileye
MBLY
+$13.5M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$4.67M

Top Sells

Rank Stock Value
1
PDD icon
Pinduoduo
PDD
+$92.2M
2
SUZ icon
Suzano
SUZ
+$31.3M
3
ICVX
Icosavax, Inc. Common Stock
ICVX
+$21.8M
4
IDYA icon
IDEAYA Biosciences
IDYA
+$21.5M
5
XYZ
Block Inc
XYZ
+$21.3M

Sector Composition

Rank Sector Weight
1 Technology 19.71%
2 Energy 16.06%
3 Consumer Discretionary 15.49%
4 Industrials 14.8%
5 Financials 14.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DDL
26
Dingdong
DDL
$503M
$11.4M 0.46%
9,316,162
+7,217
+0.1% +$9.3K
HTHT icon
27
Huazhu Hotels Group
HTHT
$13B
$11.2M 0.45%
288,942
-54,188
-16% -$1.89M
APGE icon
28
Apogee Therapeutics
APGE
$10.2B
$11.2M 0.45%
167,878
-115,805
-41% -$5.06M
V icon
29
Visa
V
$677B
$9.64M 0.39%
34,544
+6,851
+25% +$1.89M
ADBE icon
30
Adobe
ADBE
$105B
$8.97M 0.36%
17,768
+448
+3% +$257K
BCYC
31
Bicycle Therapeutics
BCYC
$292M
$8.29M 0.33%
333,001
-29,079
-8% -$618K
AMZN icon
32
Amazon
AMZN
$2.96T
$7.82M 0.32%
43,330
+18,667
+76% +$3.12M
IDYA icon
33
IDEAYA Biosciences
IDYA
$3.56B
$7.13M 0.29%
162,554
-499,789
-75% -$21.5M
ROIV icon
34
Roivant Sciences
ROIV
$26.2B
$7.05M 0.28%
669,047
– –
VERA icon
35
Vera Therapeutics
VERA
$2.36B
$6.64M 0.27%
153,932
-46,370
-23% -$1.65M
JNJ icon
36
Johnson & Johnson
JNJ
$625B
$6.3M 0.25%
39,813
-2,834
-7% -$451K
IMVT icon
37
Immunovant
IMVT
$8.25B
$6.16M 0.25%
190,656
-38,109
-17% -$1.39M
GOSS icon
38
Gossamer Bio
GOSS
$87M
$5.54M 0.22%
4,694,065
-2,260,045
-32% -$2.49M
CNTA
39
DELISTED
Centessa Pharmaceuticals
CNTA
$5.48M 0.22%
485,174
+104,091
+27% +$986K
QTRX icon
40
Quanterix
QTRX
$190M
$5.12M 0.21%
217,442
-293,311
-57% -$7.27M
INBX
41
DELISTED
Inhibrx, Inc. Common Stock
INBX
$5.1M 0.21%
145,966
-21,797
-13% -$795K
CSGP icon
42
CoStar Group
CSGP
$12.3B
$4.83M 0.19%
+50,000
New +$4.3M
MRUS
43
DELISTED
Merus
MRUS
$4.48M 0.18%
99,490
-42,539
-30% -$1.73M
ABSI icon
44
Absci
ABSI
$1.51B
$4.41M 0.18%
776,602
-60,994
-7% -$275K
ZYME icon
45
Zymeworks
ZYME
$1.67B
$4.4M 0.18%
418,376
+8,537
+2% +$94.8K
BKNG icon
46
Booking.com
BKNG
$161B
$4.3M 0.17%
29,625
-56,025
-65% -$7.99M
ESPR
47
DELISTED
Esperion Therapeutics
ESPR
$4.28M 0.17%
1,597,542
-1,213,013
-43% -$2.95M
NFLX icon
48
Netflix
NFLX
$309B
$4.04M 0.16%
66,480
-12,900
-16% -$727K
RCUS icon
49
Arcus Biosciences
RCUS
$3.64B
$3.86M 0.16%
204,398
– –
BNTX icon
50
BioNTech
BNTX
$23.5B
$3.86M 0.16%
41,815
-37,737
-47% -$3.62M
1
2
3 4 5

Similar funds

LCG
Lisanti Capital Growth New York $397M AUM 178.66% 1-Year Est. Return
EH
EMG Holdings Old Greenwich, Connecticut $397M AUM 9.97% 1-Year Est. Return
TPWA
Twin Peaks Wealth Advisors Burlingame, California $397M AUM 23.23% 1-Year Est. Return
VC
Vision Capital Toronto, Ontario, Canada $397M AUM 0.8% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
GPC
Greenstone Partners & Co Larkspur, California $395M AUM 35.56% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Platinum Investment Management's Q1 2024 Portfolio in Review

As of Q1 2024, Platinum Investment Management held 157 positions worth $2.48B, up 0.72% from $2.46B the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Platinum Investment Management withdrew a net $127M in Q1 2024, closing 18 positions and reducing 63 holdings. Its most notable exit was Icosavax, Inc. Common Stock, an estimated $21.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 14% a quarter earlier, followed by Energy and Consumer Discretionary.

Against the trend, Platinum Investment Management opened a new position in CoStar Group worth $4.83M.

  • Platinum Investment Management's largest Q1 2024 buy was CoStar Group: 50,000 shares worth $4.83M.
  • Platinum Investment Management added most to Broadcom in Q1 2024, an estimated $126M increase.
  • Platinum Investment Management's biggest Q1 2024 reduction was Pinduoduo, cutting an estimated $92.2M.
  • Platinum Investment Management fully exited Icosavax, Inc. Common Stock in Q1 2024, selling an estimated $21.8M.
  • Platinum Investment Management's ten largest holdings make up 65% of its $2.48B portfolio in Q1 2024.
  • Platinum Investment Management opened 15 new positions and closed 18 in Q1 2024.
  • Platinum Investment Management's portfolio value rose 0.72% quarter-over-quarter to $2.48B.

Based on Platinum Investment Management's 13F filing for Q1 2024, filed 13 May 2024.